Comparison of virus shedding after lived attenuated and pentavalent reassortant rotavirus vaccine

Vaccine

Volumn 32, Issue 10, 2014, Pages 1199-1204

  Hsieh, Yu Chia ^a   Wu, Fang Tzy ^b   Hsiung, Chao A ^c   Wu, Ho Sheng ^b   Chang, Kuang Yi ^d,e   Huang, Yhu Chering ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b Centers for Disease Control   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Rotavirus vaccine; Shedding

Indexed keywords

ROTAVIRUS VACCINE; SHEDDING;

FECES; FEMALE; HUMANS; INFANT; MALE; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; TAIWAN; VACCINES, ATTENUATED; VIRUS SHEDDING;

EID: 84893946206     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.08.041     Document Type: Article

References (25)

1. Curns A.T., Steiner C.A., Barrett M., Hunter K., Wilson E., Parashar U.D. Reduction in acute gastroenteritis hospitalizations among US children after introduction of rotavirus vaccine: analysis of hospital discharge data from 18 US states. J Infect Dis 2010, 201:1617-1624.
2. Patel M.M., Lopez-Collada V.R., Bulhoes M.M., De Oliveira L.H., Bautista Marquez A., Flannery B., et al. Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil. N Engl J Med 2011, 364:2283-2292.
3. Richardson V., Hernandez-Pichardo J., Quintanar-Solares M., Esparza-Aguilar M., Johnson B., Gomez-Altamirano C.M., et al. Effect of rotavirus vaccination on death from childhood diarrhea in Mexico. N Engl J Med 2010, 362:299-305.
4. Boom J.A., Tate J.E., Sahni L.C., Rench M.A., Hull J.J., Gentsch J.R., et al. Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States. Pediatrics 2010, 125:e199-e207.
5. de Palma O., Cruz L., Ramos H., de Baires A., Villatoro N., Pastor D., et al. Effectiveness of rotavirus vaccination against childhood diarrhoea in El Salvador: case-control study. BMJ 2010, 340:c2825.
6. Correia J.B., Patel M.M., Nakagomi O., Montenegro F.M., Germano E.M., Correia N.B., et al. Effectiveness of monovalent rotavirus vaccine (Rotarix) against severe diarrhea caused by serotypically unrelated G2P [4] strains in Brazil. J Infect Dis 2010, 201:363-369.
7. Snelling T.L., Schultz R., Graham J., Roseby R., Barnes G.L., Andrews R.M., et al. Rotavirus and the indigenous children of the Australian outback: monovalent vaccine effective in a high-burden setting. Clin Infect Dis 2009, 49:428-431.
8. Braeckman T., Van Herck K., Meyer N., Pircon J.Y., Soriano-Gabarro M., Heylen E., et al. Effectiveness of rotavirus vaccination in prevention of hospital admissions for rotavirus gastroenteritis among young children in Belgium: case-control study. BMJ 2012, 345:e4752.
9. Phua K.B., Quak S.H., Lee B.W., Emmanuel S.C., Goh P., Han H.H., et al. Evaluation of RIX4414, a live, attenuated rotavirus vaccine, in a randomized, double-blind, placebo-controlled phase 2 trial involving 2464 Singaporean infants. J Infect Dis 2005, 192(Suppl. 1):S6-S16.
10. Dennehy P.H., Brady R.C., Halperin S.A., Ward R.L., Alvey J.C., Fischer F.H., et al. Comparative evaluation of safety and immunogenicity of two dosages of an oral live attenuated human rotavirus vaccine. Pediatr Infect Dis J 2005, 24:481-488.
11. Payne D.C., Edwards K.M., Bowen M.D., Keckley E., Peters J., Esona M.D., et al. Sibling transmission of vaccine-derived rotavirus (RotaTeq) associated with rotavirus gastroenteritis. Pediatrics 2010, 125:e438-e441.
12. Boom J.A., Sahni L.C., Payne D.C., Gautam R., Lyde F., Mijatovic-Rustempasic S., et al. Symptomatic infection and detection of vaccine and vaccine-reassortant rotavirus strains in 5 children: a case series. J Infect Dis 2012, 206:1275-1279.
13. Rivera L., Peña L.M., Stainier I., Gillard P., Cheuvart B., Smolenov I., et al. Horizontal transmission of a human rotavirus vaccine strain-a randomized, placebo-controlled study in twins. Vaccine 2011, 29:9508-9513.
14. Pang X.L., Lee B., Boroumand N., Leblanc B., Preiksaitis J.K., Yu Ip C.C. Increased detection of rotavirus using a real time reverse transcription-polymerase chain reaction (RT-PCR) assay in stool specimens from children with diarrhea. J Med Virol 2004, 72:496-501.
15. Helen B., Robin P. Applied mixed models in medicine 1999, 199-260. J. Wiley & Sons, New York.
16. Yen C., Jakob K., Esona M.D., Peckham X., Rausch J., Hull J.J., et al. Detection of fecal shedding of rotavirus vaccine in infants following their first dose of pentavalent rotavirus vaccine. Vaccine 2011, 29:4151-4155.
17. Merk and Company. RotaTeq (Prescribing Information). Whitehouse Station NMCI.
18. Ruiz-Palacios G.M., Guerrero M.L., Bautista-Marquez A., Ortega-Gallegos H., Tuz-Dzib F., Reyes-Gonzalez L., et al. Dose response and efficacy of a live, attenuated human rotavirus vaccine in Mexican infants. Pediatrics 2007, 120:e253-e261.
19. Vesikari T., Karvonen A., Korhonen T., Espo M., Lebacq E., Forster J., et al. Safety and immunogenicity of RIX4414 live attenuated human rotavirus vaccine in adults, toddlers and previously uninfected infants. Vaccine 2004, 22:2836-2842.
20. Vesikari T., Matson D.O., Dennehy P., Van Damme P., Santosham M., Rodriguez Z., et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006, 354:23-33.
21. Freeman M.M., Kerin T., Hull J., McCaustland K., Gentsch J. Enhancement of detection and quantification of rotavirus in stool using a modified real-time RT-PCR assay. J Med Virol 2008, 80:1489-1496.
22. Bernstein D.I., Smith V.E., Sherwood J.R., Schiff G.M., Sander D.S., DeFeudis D., et al. Safety and immunogenicity of live, attenuated human rotavirus vaccine 89-12. Vaccine 1998, 16:381-387.
23. Vesikari T., Clark H.F., Offit P.A., Dallas M.J., DiStefano D.J., Goveia M.G., et al. Effects of the potency and composition of the multivalent human-bovine (WC3) reassortant rotavirus vaccine on efficacy, safety and immunogenicity in healthy infants. Vaccine 2006, 24:4821-4829.
24. Clark H.F., Borian F.E., Modesto K. Plotkin SA. Serotype 1 reassortant of bovine rotavirus WC3, strain WI79-9, induces a polytypic antibody response in infants. Vaccine 1990, 8:327-332.
25. Anderson E.J. Rotavirus vaccines: viral shedding and risk of transmission. Lancet Infect Dis 2008, 8:642-649.